Elan's Irish Tax Base Becomes Perrigo's Pot of Gold
July 29 (Bloomberg) -- Bloomberg's Olivia Sterns reports on the $8.6 billion by Perrigo Co. to purchase Irish drug company Elan Corp. and the tax relief Ireland's tax-base may bring to the drugmaker, plus a look at what may be a split of internal operations by Pfizer. She speaks on Bloomberg Television's "Market Makers."
Most Recent Videos
El-Erian Says Wage Growth Is Key to Fed's March Decision
09:30 - Mohamed El-Erian, chief economic adviser at Allianz and Bloomberg View columnist, explains how the February jobs report can affect market expectations for an interest rate cut at the Federal Reserve's March meeting. He speaks with Bloomberg's Alix Steel on "Bloomberg Daybreak: Americas." (El-Erian is a Bloomberg View columnist. The opinions expressed are his own.) (Source: Bloomberg)